LGALS9 and autoimmune disease: Gal-9 is a β-galactoside binding lectin that exhibits therapeutic effects in autoimmune disease models, such as autoimmune arthritis, experimental allergic encephalomyelitis, and Type 1 diabetes mellitus [5], [6], [7].